Official UK procurement notice
Provision of a Systemic Anti-Cancer Therapy (SACT) Compounding and Nursing Service
Authority: NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) (Central government)
What is being bought
Published requirement descriptionThe NHS Wales Shared Services Partnership (hosted by Velindre NHS Trust) are acting on behalf of Velindre NHS Trust who sought to award a contract for a Parenteral Systemic Anti-cancer Therapy (SACT) service. This service is to be provided on behalf of Velindre Cancer Centre which is part of Velindre University NHS Trust.
In recent years there has been a surge of new SACT approved by NICE / AWMSG, including immunotherapy to treat solid tumour cancers. This surge is associated with significant increased demand and associated pressure on resources, which will continue to grow as more drugs / indications are NICE approved. This requirement is to increase capacity in order to help meet SACT demand as required. The Medicines@Home Service, as part of the Pharmacy department at Velindre Cancer Centre, will operationally manage the service.
CPV: Administrative healthcare services · Supply services of nursing personnel
The lotProcurement structure
single lot · no lot value publishedLot #1The NHS Wales Shared Services Partnership, are acting on behalf of Velindre University…AwardedRenewal
The NHS Wales Shared Services Partnership, are acting on behalf of Velindre University NHS Trust who sought to establish a contract for a Parenteral Systemic Anti-cancer Therapy (SACT) service to be provided on behalf of Velindre Cancer Centre which is part of Velindre University NHS Trust.
The purpose is to provide SACT services on behalf of Velindre Cancer Centre (a division of Velindre University NHS Trust). This includes the nursing, compounding and facility to provide a SACT service.
In recent years there has been a surge of new SACT approved by NICE / AWMSG including immunotherapy to treat solid tumour cancers. This surge is associated with significant increased demand on service resource implications: i.e. medical, nursing and pharmacy staff which is expected to continue to grow as more drugs / indications are NICE approved.
What it takes to wini
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
Evaluation split and conditions of participation as published; the tender pack may add morei
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
Published sub-criteria (2)
- Qualitative: 60%
- Commercial: 40%
Published award criteria (2)
- Qualitative: 60
- Commercial: 40
- Technical & professional ability
Bidder must be a member of the National Homecare Committee.
Bidder must have MHRA Whole Sales Dealers Licence.
- Staff
- Names and qualifications of delivery staff must be submitted
- Price carries 40 of 100 points: a 10% discount moves about 4 points. The method statement decides this lot, not the discount.
Price arithmetic assumes straight proportional scoring; the tender pack may use another formula.
Procedure terms & legal framework
From the official record · publisher note attached- Procedure method
- Open procedure
- Legal basis
- CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
- Procurement category
- Services
- Notice status
- Awarded
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Stand-alone contract (no framework)
- Competition type
- Competitive procedure
- GPA / WTO covered
- Yes (GPA)
- Recurring procurement
- No (one-off requirement)
- First published
- 18 Dec 2023, 09:40 GMT
- Last source update
- 29 Apr 2024, 11:21 BST
- Award evaluation window
- 22 Jan 2024 – …
- Authority reference
VEL-OJEU-PROJECT_54813- FTS notice number
2024/S 000-013708- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-04264fFind a Tender
- Electronic trading
- e-invoicing allowed · electronic ordering · electronic payment
- Review procedure
NHS Wales Shared Services Partnership on behalf of Cardiff and Vale University Local Health Board will allow a minimum 10 calendar day standstill period between notifying the award decision and awarding the contract. Unsuccessful tenderers and applicants are entitled to receive reasons for the decision, including the characteristics and relative advantages of the winning bid and the reasons why the tenderer/applicant was unsuccessful.
Should additional information be required it should be requested of the addressee in section I.1. Aggrieved parties who have been harmed or are at risk of harm by breach of the procurement rules have the right to take action in the High Court (England and Wales). Any such action is subject to strict time limits in accordance with the Public Contracts (Amendments) Regulations 2015.
Publisher note: Please note additional information on this procurement: 1. The Contracting Authority reserves the right to award the contract in whole, in part or annul the tendering process and not award any contract. 2. Bidders should note that they will be required to enter into terms and conditions of contract as set out in the ITT and that save for matters of clarification or consistency the Contracting Authority will not negotiate the terms. 3. The Contracting Authority will not accept completed ITT's after the stated closing date. 4. All documents to be priced (where applicable) in sterling and all payments made in sterling. 5. All tender costs and liabilities incurred by bidders shall be the sole responsibility of the bidders. 6. Prospective suppliers should note that NHS Shared Services Partnership - Procurement Services is acting on behalf of Velindre NHS Trust. 7. Bidders wishing to participate should visit the Bravo e-tenderwales portal and access itt_107325. (WA Ref:141034)
How it was run
Official notice- Submission deadline
- 22 Jan 2024, 16:00 GMT
- Submission channel
- {"electronicSubmission"}
- Accepted languages
- en, cy
- Bid validity
- 180 days from the deadline
- Bids opened
- 22 Jan 2024, 16:00 GMT
Timeline
22 Jan 2024 → 29 Apr 2024 · 3 dates- Submission deadline22 Jan 2024, 16:00 GMT
- Bids opened22 Jan 2024, 16:00 GMT
- Notice published29 Apr 2024, 11:21 BST
Notice history
1 event · 2 releases on Find a Tender- Status changed to complete29 Apr 2024, 11:21 BST
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast| Awarded to | Value | Date | Status |
|---|---|---|---|
| LloydsPharmacy | £4,201,314 † | — | Awarded |
Contracts
Contract 013708-2024-VEL-OJEU-PROJECT_54813-1 · LloydsPharmacy
- Signed
- 29 Apr 2024
- Value
- £4,201,314
- Status
- active
Bid statistics published by the authority
| Bids | SME | VCSE | Valid bid range |
|---|---|---|---|
| 1bids · 1 electronic · 1 from abroad | 0 | — | — |
Contracting authority & participating public bodies
Dispute resolution & review bodies
- High CourtReview body
Bidders & participating suppliers
1 commercial party on the notice- LloydsPharmacyAwarded supplier
Official documents & specifications (2)
Official links; attachments are not copiedTender pack and attachments
- Economic and financial selection criteria
- Technical selection criteria